Video

MPN Heroes® Recognition Program 2020

Author(s):

CURE Media Group

Watch the entire MPN Heroes program here!

CURE® and Incyte Corporation were proud to host the eighth annual MPN Heroes® recognition program as a virtual celebration! In the spirit of fostering community, participants were invited to join the cancer community for an evening of gratitude for the heroes who have made differences in the lives of people with MPNs. 

Each MPN Hero was nominated by patients, caregivers and health care professionals for their heroic contributions in the field of MPN cancer or in the individual lives of people with MPN cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of Dr. Tiziano Barbui
Image of doctor.
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Image of Crispino
Picture of Joy Anderson
Image of doctor.
Dr. Richard “Rick" Winneker
Image of man with grey hair.
Related Content
Image of blood cells.
June 11th 2025

Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

Ryan Scott
Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
blood cells.
May 29th 2025

Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis

Ryan Scott
A patient and provider share updates on pelabresib plus Rituxan treatment, which met the MANIFEST-2 trial's primary end point for those with myelofibrosis.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
December 16th 2021

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Image of blood cells.
May 6th 2025

Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV

Ryan Scott
Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera.
Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis: © stock.adobe.com
April 19th 2025

Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis

Alex Biese
Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, according to the ROMEI clinical trial.